N* | Baseline | 2-weeks follow-up | P** | |
---|---|---|---|---|
PROMs | ||||
BASDAI, 0–10 scale | 59 | 4.3 (2.2) | 3.1 (2.1) | <0.001 |
BASFI, 0–10 scale | 57 | 3.1 (1.9) | 2.3 (2.0) | <0.001 |
Therapist measured outcomes | ||||
BASMI, 0–10 scale | 87 | 3.2 (2.4) | 2.3 (2.4) | <0.001 |
Gait velocity, m/s | 83 | 2.2 (0.5) | 2.7 (0.6) | <0.001 |
Timed-stand test, s | 86 | 21.8 (8.1) | 15.8 (4.8) | <0.001 |
Finger-to-floor distance, cm | 49 | 15.1 (14.0) | 9.1 (12.7) | <0.001 |
11.0 [25.0] | 0 [16.0] | <0.001 | ||
Chest expansion, cm | 46 | 3.7 (2.2) | 4.7 (2.3) | <0.001 |
Laboratory data | ||||
ESR, mm/hr | 32 | 22.6 (23.4) | 18.7 (15.3) | 0.21 |
14.0 [17.0] | 16.0 [22.8] | 0.44 | ||
CRP, mg/l | 47 | 10.3 (13.7) | 9.3 (10.7) | 0.59 |
5.0 [7.1] | 4.4 [15.6] | 0.71 |